Clinical Trial Update: A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for DC-CIK immunotherapy in solid tumors; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Kidney Cancer
• Liver Cancer
• Lung Cancer
• Nasopharyngeal Cancer

Drugs mentioned

• DC-CIK immunotherapy (dendritic cell-cytokine-induced killer cell therapy)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Liver Cancer, Kidney Cancer | Phase 2 | Status: UNKNOWN